Upload
shruti-vikram
View
13
Download
2
Embed Size (px)
DESCRIPTION
ppt on biocon co
Citation preview
Industry: Biotechnology Founders, Chairman &M.D: Kiran
Mazumdar Shaw Founded:1978 Headquarters: Bangalore Employees:6000(approx)
SHAREHOLDERS PERCENTAGE
Employees Trust 13%
Promoters 65%
Public 22%
1978:-Indian’s #1 Biotech company with a global biotech ranking of 16
1979:-Global leadership in specialty enzymes
1989:-Globally unique fermentation profile
1994:-SYNGENE-India’s first research company
2003:- India’s first and largest Antibody Facility-Clinigene
Revenue:-240 million US$(2011-12) Profit:-39 million US$(2011-12) Traded as BIOCON in NSE Face Value: Rs 5 Market Cap:-9222 crore EPS:- Rs. 15.43 P/E Ratio:29.83
Biotechnology has transformed many parts of the chemical industry, agriculture and medicine.
The consumption of biotech products in India was expected to quadruple within a decade.
The human and animal segment of the industry alone was growing by at least 20%.
From 2009, Indian Biotech Industry contributes to 3.5% of the global biotech industry.
In India 800 Companies were operating in all sectors of biotechnology, but only 25 were working in the modern biotech sectors.
Government is implementing a national Biotechnology Development Strategy (NBDS) and establishing a national Biotechnology Regulatory Authority (NBRA) .
100% FDI in biotechnology sector.
Special tax benefits.
THANK YOU